AffiAB® Anti-IKB beta Antibody [SN0648]
NF-kappa-B inhibitor beta is a protein that in humans is encoded by the NFKBIB gene. NFKB1 or NFKB2 is bound to REL, RELA, or RELB to form the NFKB complex. The NFKB complex is inhibited by I-kappa-B proteins (NFKBIA or NFKBIB) , which inactivate NF-kappa-B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I-kappa-B proteins by kinases (IKBKA or IKBKB) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF-kappa-B complex. Activated NFKB complex translocates into the nucleus and binds DNA at kappa-B-binding motifs such as 5-prime GGGRNNYYCC 3-prime or 5-prime HGGARNYYCC 3-prime (where H is A, C, or T; R is an A or G purine; and Y is a C or T pyrimidine) .
Antibody type
Recombinant Rabbit monoclonal Antibody
Uniprot ID
SwissProt: Q15653 Human
Recombinant
YES
Conjugation
Non-conjugated
Host
Rabbit
Isotype
IgG
Clone
SN0648
KO/KD
N/A
Species reactivity
Human
Tested applications
WB, IF-Cell, IHC-P, IP
Predicted species reactivity
N/A
Immunogen
Synthetic peptide within Human IKB beta aa 322-356 / 356.
Storage
Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Form
Liquid
Storage buffer
1*TBS (pH7.4) , 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
1 mg/mL.
Purity
Protein A affinity purified.
Signal pathway
Immunology & Inflammation
Recommended dilutions
WB: 1:500-1:1, 000; IF-Cell: 1:50-1:200; IHC-P: 1:50-1:200; IP: Use at an assay dependent concentration.
Molecular Weight
Predicted band size: 38 kDa
Subcellular location
Nucleus, Cytoplasm.
Positive control
Hela cell lysate, Jurkat cell lysate, A549, MCF-7, human breast carcinoma tissue.